Red Light Holland and Halo Labs Announce Intention to Enter Oregon Medicinal Psilocybin Market Post published:November 20, 2020 Post category:Press Release
Psychedelic Bulletin: Non-Palliative Canadian Receives Psilocybin Therapy; Germany Backs Psilocybin Study; MindMed Moves Forward with LSD for ADHD Trial Post published:November 20, 2020 Post category:Psychedelic Bulletin
Mind Cure Announces Closing of Oversubscribed $3.6 Million Offering Post published:November 19, 2020 Post category:Press Release
Nick Milne, Co-founder and CSO at Octarine Bio Post published:November 19, 2020 Post category:Interview
Field Trip Health Ltd. and WHOOP announce partnership to measure effect of psychedelic therapies on physiology and mental health Post published:November 19, 2020 Post category:Press Release
Psilocybin for Depression Study Approved and Funded by German Government Post published:November 19, 2020 Post category:Clinical Trials/News
NeonMind Commences Preclinical Trial to Examine Psilocybin for Weight Loss Post published:November 19, 2020 Post category:Press Release
Nova Mentis Life Science Announces Receipt of Pilz Shareholder Approval Post published:November 18, 2020 Post category:Press Release
Numinus Announces Compassionate Access Trial of Psilocybin-Assisted Psychotherapy for Substance Use Disorders Post published:November 18, 2020 Post category:Press Release
PharmaTher Enters Into Research Collaboration with Revive Therapeutics for Psilocybin and panaceAI⢠Psychedelic Discovery AI Platform Post published:November 18, 2020 Post category:Press Release